Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 113, 104375
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81760131)
- Natural Science Foundation of Guizhou Province
This publication has 29 references indexed in Scilit:
- Smad phospho-isoforms direct context-dependent TGF-β signalingCytokine & Growth Factor Reviews, 2013
- Transforming Growth Factor-β/SMAD Target Gene SKIL Is Negatively Regulated by the Transcriptional Cofactor Complex SNON-SMAD4Journal of Biological Chemistry, 2012
- TGF-β/Smad Signaling in Kidney DiseaseSeminars in Nephrology, 2012
- Dynamics and feedback loops in the transforming growth factor β signaling pathwayBiophysical Chemistry, 2012
- Smad phosphoisoform signaling specificity: the right place at the right timeCarcinogenesis, 2011
- Phosphorylation of the Anaphase-promoting Complex/Cdc27 Is Involved in TGF-β SignalingJournal of Biological Chemistry, 2011
- Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivoNephrology, 2010
- Smad2 Protects against TGF-β/Smad3-Mediated Renal FibrosisJournal of the American Society of Nephrology, 2010
- Requirement for the SnoN Oncoprotein in Transforming Growth Factor β-Induced Oncogenic Transformation of Fibroblast CellsMolecular and Cellular Biology, 2005
- The Endogenous Ratio of Smad2 and Smad3 Influences the Cytostatic Function of Smad3Molecular Biology of the Cell, 2005